Home › Investigational Brain Cancer Vaccine Produces Strong Immunological Response
 

Keywords :   


Investigational Brain Cancer Vaccine Produces Strong Immunological Response

2015-04-22 05:44:58| drugdiscoveryonline Home Page

A first-of-its kind cancer vaccine, SurVaxM, has demonstrated safety and tolerability in patients with recurrent or progressive malignant brain tumors, according to results of a phase I study conducted by Roswell Park Cancer Institute (RPCI) researchers.

Tags: strong response cancer brain

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
04.07Atlantic Tropical Weather Outlook
04.07Hurricane Beryl Graphics
04.07Hurricane Beryl Public Advisory Number 24A
04.07Summary for Hurricane Beryl (AT2/AL022024)
04.07Eastern North Pacific Tropical Weather Outlook
04.07 Mankiewicz Supplies Eye-catching Coatings for the CLAAS Anniversary Combine Harvester
04.07AR/VR panel shipments to increase 12% in 2024
04.07Astro Malaysia presents results for quarter ended 30 April 2024
More »